Evidence map›Paper›PMID 16336654›Full record

ArticleJournal of negative results in biomedicine2005

Beta-defensin genomic copy number is not a modifier locus for cystic fibrosis.

Edward J Hollox, Jane Davies, Uta Griesenbach, Juliana Burgess, Eric W F W Alton, John A L Armour

Open access · hybridAbstract read
In one paragraph

Article in Journal of negative results in biomedicine, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Human defensins and LL-37 in mucosal immunity.Journal of leukocyte biology · 2010
    Review
  11. Article
  12. Allelic recombination between distinct genomic locations generates copy number diversity in human beta-defensins.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Article
  13. Update on gene modifiers in cystic fibrosis.Current opinion in pulmonary medicine · 2008
    Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Edward J HolloxInstitute of Genetics, University of Nottingham, Nottingham, UK. ed.hollox@nottingham.ac.uk
Jane Davies
Uta Griesenbach
Juliana Burgess
Eric W F W Alton
John A L Armour
Imperial College London · GBUniversity of Nottingham · GBRoyal Brompton Hospital · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Human beta-defensin 2 (DEFB4, also known as DEFB2 or hBD-2) is a salt-sensitive antimicrobial protein that is expressed in lung epithelia. Previous work has shown that it is encoded in a cluster of beta-defensin genes at 8p23.1, which varies in copy number between 2 and 12 in different individuals. We determined the copy number of this locus in 355 patients with cystic fibrosis (CF), and tested for correlation between beta-defensin cluster genomic copy number and lung disease associated with CF. No significant association was found.

Indexed as

Allelesbeta-DefensinsCohort StudiesCystic FibrosisDiploidyDNA ProbesGene DosageGenome, HumanHumansbeta-DefensinsDNA Probes

Identifiers

PMID16336654
PMCPMC1318481
OpenAlexW2160873069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.